Qiagen (QGEN) Set to Announce Earnings on Wednesday

Qiagen (NYSE:QGEN) will be announcing its earnings results after the market closes on Wednesday, November 6th. Analysts expect the company to announce earnings of $0.54 per share for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.

Qiagen (NYSE:QGEN) last released its quarterly earnings results on Wednesday, July 31st. The company reported $0.55 earnings per share for the quarter, topping the consensus estimate of $0.52 by $0.03. Qiagen had a net margin of 3.75% and a return on equity of 12.92%. The business had revenue of $496.00 million for the quarter, compared to the consensus estimate of $495.45 million. During the same period last year, the firm earned $0.53 earnings per share. The company’s quarterly revenue was down .2% on a year-over-year basis. On average, analysts expect Qiagen to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Qiagen Trading Up 0.1 %

Shares of QGEN stock opened at $41.83 on Wednesday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.77 and a quick ratio of 1.46. The company has a market cap of $9.55 billion, a price-to-earnings ratio of 28.07, a PEG ratio of 3.17 and a beta of 0.39. Qiagen has a 1 year low of $34.74 and a 1 year high of $47.44. The firm has a fifty day moving average price of $44.58 and a 200-day moving average price of $43.56.

Analysts Set New Price Targets

A number of analysts have commented on the company. Robert W. Baird upped their price target on Qiagen from $49.00 to $52.00 and gave the stock an “outperform” rating in a research report on Friday, August 2nd. HSBC lowered shares of Qiagen from a “buy” rating to a “hold” rating and set a $49.00 target price for the company. in a report on Thursday, October 17th. Finally, Hsbc Global Res raised shares of Qiagen to a “hold” rating in a report on Thursday, October 17th. Five analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $50.12.

About Qiagen

QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories.